tetano
Editor, Senior Moderator
Intern Med
. 2024 Mar 4.
doi: 10.2169/internalmedicine.3096-23. Online ahead of print. An Autopsy Case of COVID-19 with New Diffuse Pulmonary Ossification
Taisuke Nakagawa[SUP] 1 2 [/SUP], Yasuaki Kotetsu[SUP] 1 [/SUP], Katsumi Takizawa[SUP] 3 [/SUP], Michihiro Yoshimi[SUP] 2 [/SUP], Isamu Okamoto[SUP] 1 [/SUP], Shohei Takata[SUP] 2 [/SUP]
Affiliations
We present the case of a 61-year-old man who developed Coronavirus disease 2019 (COVID-19) and died during treatment for relapsing polychondritis. The patient was intubated and treated with steroid pulse therapy, remdecivir, antibacterial agents, baricitinib, and tocilizumab. However, his respiratory condition worsened, and he died 108 days after disease onset. An autopsy revealed diffuse alveolar damage in the fibrotic phase in all lung lobes, diffuse pulmonary ossification, and cytomegalovirus-infected cells in the middle lobe of the right lung. We herein discuss the clinical features and pathological findings of COVID-19 in immunosuppressed patients.
Keywords: COVID-19; diffuse alveolar damage; diffuse pulmonary ossification.
. 2024 Mar 4.
doi: 10.2169/internalmedicine.3096-23. Online ahead of print. An Autopsy Case of COVID-19 with New Diffuse Pulmonary Ossification
Taisuke Nakagawa[SUP] 1 2 [/SUP], Yasuaki Kotetsu[SUP] 1 [/SUP], Katsumi Takizawa[SUP] 3 [/SUP], Michihiro Yoshimi[SUP] 2 [/SUP], Isamu Okamoto[SUP] 1 [/SUP], Shohei Takata[SUP] 2 [/SUP]
Affiliations
- PMID: 38432960
- DOI: 10.2169/internalmedicine.3096-23
We present the case of a 61-year-old man who developed Coronavirus disease 2019 (COVID-19) and died during treatment for relapsing polychondritis. The patient was intubated and treated with steroid pulse therapy, remdecivir, antibacterial agents, baricitinib, and tocilizumab. However, his respiratory condition worsened, and he died 108 days after disease onset. An autopsy revealed diffuse alveolar damage in the fibrotic phase in all lung lobes, diffuse pulmonary ossification, and cytomegalovirus-infected cells in the middle lobe of the right lung. We herein discuss the clinical features and pathological findings of COVID-19 in immunosuppressed patients.
Keywords: COVID-19; diffuse alveolar damage; diffuse pulmonary ossification.